Industry: Healthcare
Published Date: November-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 192
Report ID: PMRREP34953
The global hyaluronic acid based dermal fillers market is predicted to reach a size of US$ 4.8 Bn by 2024. It is expected to witness a CAGR of 7.8% during the assessment period to reach the size of US$ 8.1 Bn by 2031. Increase in disposable incomes in developing economies is further increasing individual ability and willingness to spend on aesthetic procedures.
The aging elderly population, specifically in regions like Asia Pacific, Europe, and North America poses a rising demand for cosmetic procedures, including using Hyaluronic Acid (HA) fillers. According to the United Nations, the number of people aged 60 years or older is estimated to reach 3.4 billion by 2050, thereby driving a demand for anti-aging treatments.
Monophasic fillers, known for their longevity and versatile applications, are specifically witnessing a significant uptake. Restylane Kysse, approved by the U.S. FDA has bolstered the presence of biphasic fillers in the market.
Key Highlights of the Industry
|
Market Attributes |
Key Insights |
|
Hyaluronic Acid Based Dermal Fillers Market Size (2024E) |
US$ 4.8 Bn |
|
Projected Market Value (2031F) |
US$ 8.1 Bn |
|
Global Market Growth Rate (CAGR 2024 to 2031) |
7.8% |
|
Historical Market Growth Rate (CAGR 2019 to 2023) |
6.9% |
Germany is a leading player in the Europe Market. Investment in medical aesthetics to foster expansion in Germany. It benefits from a well-established infrastructure and an elevated consumer awareness regarding cosmetic procedures. Germany market to secure a CAGR of 8.6% through 2031.
Hyaluronic acid based dermal fillers are especially popular in Germany owing to their ability to address facial wrinkles and volume loss without the requirement for surgery. Germany market for hyaluronic acid based dermal fillers is estimated to quickly expand as consumers in the country seek quick and effective solutions with minimal recovery times. As a part of the Europe, Germany is increasingly benefiting from increasing investments in medical aesthetics and innovative product offerings.
Aesthetic treatments are highly sought after in South Korea with dermal fillers accounting for a significant portion of the hyaluronic acid market. These fillers represented the largest revenue generating segment in 2022. South Korea to exhibit a CAGR of 8.7 during the forecast period.
South Korea is popular for its advanced cosmetic procedures. The country has an increasing interest in non-invasive treatments that aligns well with the global trend toward minimally aesthetic interventions.
The aging population of the country contributes to market growth, especially in the medical use of hyaluronic acid for conditions like osteoarthritis. The country’s robust aesthetic culture and government-backed healthcare infrastructure positions South Korea as a leader in the global hyaluronic acid based dermal fillers market.
|
Category |
CAGR through 2031 |
|
Product Type – Single Phase |
8.6% |
Population across the globe is progressively adopting single phase fillers owing to their smooth texture and ease of application that leads to more natural looking results. technological innovation in crosslinking that assists in enhancing the gel’s uniformity and durability is one of the key drivers of growth.
Hyaluronic fillers with optimal crosslinking density provide smoother results along with long-lasting effects that last up to 12 to 18 months. The increasing demand for this product is also highly driven by the continuous development of single phase gels that exhibit enhanced elasticity and longevity.
|
Category |
CAGR through 2031 |
|
Application - Rhinoplasty |
8.9% |
HA based dermal filler for rhinoplasty, popularly known as non-surgical rhinoplasty or the liquid nose job has witnessed notable growth. It is gaining traction as an alternative to conventional surgical rhinoplasty as it offers patients the ability to modify the shape of their nose without undergoing any surgery.
Liquid rhinoplasty procedures, in 2022, constituted 15% to 20% of all non-surgical facial aesthetic procedures, thereby contributing to significant growth in the overall dermal filler market. The U.S. witnessed an 18% increase in non-surgical nose reshaping procedures between 2021 to 2022.
The ability to correct minor imperfections has made rhinoplasty attractive to individuals seeking subtle enhancements without the risk and downtime associated with surgical procedures. The cost-effectiveness of non-surgical rhinoplasty is another factor influencing growth.
Hyaluronic acid (HA) is a preferred choice in dermal fillers owing to their biocompatibility, minimal risk profile, and natural aesthetic results, resulting in continued dominance in the global dermal filler market. Consumers across the globe are seeking quick, effective, and safe procedures, thereby making HA-based fillers suitable for individuals looking for restoration of facial volume and other targeted therapies.
Inception of products like Juvéderm Voluma and Restylane Lyft have introduced long-lasting and less invasive solutions that cater to different skin types and facial areas, thereby increasing their appeal. The trend toward long-lasting effects of dermal fillers, with a few lasting up to 18 to 24 months, is estimated to drive continued growth in the market.
The hyaluronic acid based dermal fillers market growth was steady at a CAGR of 6.9% during the historical period. Growth during the historical period was highly driven by the rising popularity of non-invasive procedures, increased awareness about aesthetic treatments, and advancements in filler formulations.
According to The American Society of Plastic Surgeons (ASPS), the number of dermal filler treatments performed annually by 6% from 2019 to 2022, with HA based dermal fillers remaining among the top five most common non-surgical aesthetic procedures in the U.S.
The period witnessed an expansion of dermal filler treatments in emerging markets, especially in Asia Pacific and Latin America, bolstering growth. Asia Pacific witnessed massive growth in the global dermal fillers market during this period, with South Korea and China witnessing a rise in consumer demand owing to cultural shifts and increased acceptance of aesthetic procedures.
Sales of hyaluronic acid based dermal fillers are estimated to experience a CAGR of 7.8% during the forecast period.
Non-invasive Aesthetic Procedures to Witness a Surge in Demand
Individuals across the globe are opting for non-surgical treatments owing to their convenience, reduced costs compared to conventional surgical processes, and minimal recovery time.
Technological Advancements in Hyaluronic Acid Based Dermal Fillers
Technological advancements in hyaluronic acid based dermal fillers significantly enhance their effectiveness, appeal, and safety, thereby driving hyaluronic acid based dermal fillers market growth. Innovations in cross-linking technology improve the longevity and aesthetic results of these fillers.
Latest technologies like OxiFree technologies, often used in MaiLi dermal fillers by Sinclair Pharma, assist in preserving the natural properties of hyaluronic acid, leading to a natural look and long-lasting effects. Micro-needle injection techniques are revolutionizing the dermal filler application as they assist in decreasing discomfort while enhancing precision during treatment.
The use of hybrid fillers combining hyaluronic acid with other substances like calcium hydroxylapatite or poly-L-lactic acid further expands treatment options to enable customized treatments.
Regulatory Challenges likely to Surge Costs
Regulatory challenges are a significant restraint in the hyaluronic acid-based dermal filler market, thereby affecting product development, market entry, and availability. The regulatory approval process for cosmetic and medical devices varies across regions. Meeting these requirements can be time-consuming and costly for manufacturers.
In the U.S., dermal fillers must be approved by Food and Drug Administration (FDA) that involves extensive clinical trials to demonstrate the safety and efficacy of products. The lengthy process for approval is both time consuming and expensive, thereby increasing the overall costs for manufacturers, ultimately affecting product pricing and accessibility.
Dermal fillers are classified as medical devices in Europe, and therefore must comply with Medical Device Regulation (MDR), which came into effect in 2021. This mandates manufacturers to conduct rigorous testing, including clinical evaluation, post-market surveillance, and risk-assessments. This further raises costs for manufacturers, making it difficult for smaller companies to enter market.
Rise of Medical Tourism Opens up New Avenues for Growth
Medical tourism is estimated to emerge as a significant growth driver for the hyaluronic acid based dermal filler market as patients across the globe seek affordable and superior quality cosmetic procedures abroad. Several countries are offering competitive pricing and skilled professionals for aesthetic procedures, including dermal fillers, thereby attracting a rising number of international patients.
South Korea, Brazil, Turkey, India, and Thailand are the key destinations for aesthetic medical tourism as they are renowned for their advanced medical infrastructure and expertise in cosmetic treatments. Over 25% of medical tourists in South Koreas in 2022 sought aesthetic procedures, including dermal fillers.
Turkey attracts around 700,000 medical tourists annually. Many these tourists choose cosmetic enhancements owing to its cost-effective offerings that are almost 40% to 60% cheap compared to western countries where treatment charges can exceed US$600 to US$ 800 per session. Medical tourism hubs are catering to patients by bundling cosmetic procedures with travel packages, thereby offering a blend of luxury and healthcare.
Social Media Plays a Crucial Role in the Evolution of Beauty Standards
Social media and celebrity culture heavily influence beauty standards. Studies suggest that 72% of millennials and Genz consumers seek cosmetic treatments, highly inspired by social media influencers and celebrities.
Platforms like Instagram and TikTok have created a space where people can visualize and discuss facial aesthetics. This constant exposure encourages individuals to seek enhancements in their features like sharp jawlines, contoured cheekbones, and fuller lips, which are easily achievable through dermal fillers.
The young demographics, particularly Gen-Z are embracing these procedures for not just corrective purposes but for achieving “idealized” looks that resonate with current beauty trends. A report by the American Society of Plastic Surgeons stated that there was a 12% increase in dermal filler use in individuals ages 20 to 39 from 2019 to 2022.
The rise in “selfie culture” has further accelerated this trend. Enhanced cameras and filters highlight facial symmetry and features, resulting in heightened self-awareness about one’s appearance. Inclusivity in beauty standards has created diverse opportunities.
People from various ethnicities and skin types are seeking personalized filler treatments that are customized to their unique facial features. Influencers and celebrities are openly sharing their experiences with dermal fillers, assisting in destigmatizing these procedures. This transparency further encourages prospective consumers to view fillers as routine self-care rather than excessive vanity.
Leading companies in the hyaluronic acid based dermal fillers industry are leveraging the latest technologies like OxiFree HA tech to improve their product efficacy and longevity. Companies are working towards developing specific applications to cater to diverse consumer demands.
Brands are engaging in strategic acquisitions to expand their product portfolios and regional reach to enhance their dermal filler offerings. Businesses are increasing their presence in high-growth regions where there is a rising demand for aesthetic procedures owing to growing disposable incomes.
Recent Industry Developments
|
Attributes |
Details |
|
Forecast Period |
2024 to 2031 |
|
Historical Data Available for |
2019 to 2023 |
|
Market Analysis |
US$ Billion for Value |
|
Key Regions Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled in the Report |
|
|
Report Coverage |
|
|
Customization and Pricing |
Available upon request |
By Product Type
By Application
By End User
By Region
To know more about delivery timeline for this report Contact Sales
The market is estimated to reach a size of US$ 4.8 Bn by 2031.
Galderma, Bio plus Co. Ltd., and Sinclair Pharma are the leading companies in the market.
HA based fillers are the most popular injectable augmentation preparation owing to its efficacy and safety compared to other injection fillers.
These fillers typically last between 6 to 18 months.
The market is projected to witness a CAGR of 7.8% through the forecast period.
